25 May 2013
Keywords: micrologix, licenses, hepatitis, drug, canada, obtained, worldwide
Article | 09 February 2004
Canada's Micrologix has obtained worldwide rights to the antiviral celgosivir from UK-based Virogen. The agent has undergone Phase I/II
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 February 2004
24 May 2013
© 2013 thepharmaletter.com